Effects of MetAP2 Inhibition on Bioenergetics and Aging-associated Characteristics in Adipose Tissue in Healthy Participants

NAActive, not recruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 31, 2020

Primary Completion Date

March 25, 2021

Study Completion Date

December 31, 2025

Conditions
Aging
Interventions
PROCEDURE

Abdominal subcutaneous adipose tissue biopsy

"Fatty tissue biopsy- Participant will be placed in a supine position with arms placed at side while abdominal skin is marked with a skin marker and cleansed with chlorhexidine. Afterwards, the abdominal fatty tissue biopsy will be performed.~Collect fatty tissue from young and older individuals and gather data on the effect of methionine aminopeptidase protein (MetAP2) inhibition on that fatty tissue in the laboratory."

Trial Locations (1)

32803

AdventHealth Translational Research Institute, Orlando

All Listed Sponsors
lead

AdventHealth Translational Research Institute

OTHER